BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9857856)

  • 1. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
    van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
    J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure.
    Pinto YM; van Veldhuisen DJ; Tjon-Ka-Jie RT; Rooks G; Netzer T; Lie KI
    Eur J Clin Pharmacol; 1996; 50(4):265-8. PubMed ID: 8803516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Nishiyama K
    Clin Cardiol; 1997 May; 20(5):441-5. PubMed ID: 9134274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.
    Oshima S; Ogawa H; Mizuno Y; Yamashita S; Noda K; Saito T; Sumida H; Suefuji H; Kaikita K; Soejima H; Yasue H
    Am Heart J; 1997 Nov; 134(5 Pt 1):961-6. PubMed ID: 9398110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose finding studies with imidapril--a new ACE inhibitor.
    Vandenburg MJ; Mackay EM; Dews I; Pullan T; Brugier S
    Br J Clin Pharmacol; 1994 Mar; 37(3):265-72. PubMed ID: 8198936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
    Szabó BM; van Veldhuisen DJ; van der Burgh PH; Kruik J; Girbes AR; Lie KI
    J Card Fail; 1996 Sep; 2(3):185-92. PubMed ID: 8891856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
    Kinugawa T; Ogino K; Kato M; Furuse Y; Shimoyama M; Mori M; Endo A; Kato T; Omodani H; Osaki S; Miyakoda H; Hisatome I; Shigemasa C
    Gen Pharmacol; 1998 Jul; 31(1):93-9. PubMed ID: 9595286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers.
    Démolis P; Annane D; Duhazé P; Giudicelli JF
    Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
    Harder S; Thürmann PA
    Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
    Kinugawa T; Osaki S; Kato M; Ogino K; Shimoyama M; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1060-5. PubMed ID: 12390293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.
    Murdoch DR; McDonagh TA; Byrne J; Blue L; Farmer R; Morton JJ; Dargie HJ
    Am Heart J; 1999 Dec; 138(6 Pt 1):1126-32. PubMed ID: 10577444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trial.
    Sidik NP; Solomon SD; Latini R; Maggioni AP; Wright M; Gimpelewicz CR; Pitt B; McMurray JJ
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):315-21. PubMed ID: 21779784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
    Valdemarsson S; Edvinsson L; Ekman R; Hedner P; Sjöholm A
    J Intern Med; 1991 Oct; 230(4):325-31. PubMed ID: 1717629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure.
    Sheth T; Parker T; Block A; Hall C; Adam A; Pfeffer MA; Stewart DJ; Qian C; Rouleau JL;
    Am J Cardiol; 2002 Sep; 90(5):496-500. PubMed ID: 12208409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidapril in heart failure.
    Dolezal T
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):146-54. PubMed ID: 17094051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.